Biochips Market Business Development, by Report To 2030


Biochips Market Overview:

To a recent research report by Market Research Community, the Biochips Market is expected to surpass USD 21.29 Billion by the year 2030, from USD 7.20 Billion in 2021.

A Biochips Market is a collection of microarrays that are used for various biological and medical applications. Biochips are used in a wide range of applications, including gene expression analysis, DNA sequencing, protein analysis, and drug discovery. The biochips market has seen significant growth in recent years, driven by advances in technology, increasing demand for personalized medicine, and the growing need for efficient and cost-effective medical diagnostic solutions.

The Biochips Market is projected to grow at a significant pace reaching a CAGR of approximately 12.8%, over the forecast period of 2022–2030, despite a considerable fall in Product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.

Get Sample Report Here:

The study is consolidated into major segments and further into sub-segments, such as By Type (Lab-on-chip, Tissue Arrays, Protein Chips, Cell Arrays, DNA Chips), By End-use (Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, Others) to forecast the market size by value.

By Type        

·        Lab-on-chip

·        Tissue Arrays

·        Protein Chips

·        Cell Arrays

·        DNA Chips

By End-use 

·        Hospitals and Diagnostics Centers

·        Biotechnology and Pharmaceutical Companies

·        Academic & Research Institutes

·        Others

Biochips Market Trends is in great demand, and Asian nations are steadily emerging as a result of government policies that are favorable to this market and growing public understanding of the advantages of these systems. Further, regions such as the Latin America, and Europe Middle East and Africa, are expected to boost the market expansion during the forecast period.

By Region

·        North America– (U.S., Canada, Mexico)

·        Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)

·        Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)

·        Latin America- (Brazil, Argentina, Chile, Rest of Latin America)

·        Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, and other prominent players, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies, Inc.


Market Research Community


Contact no.: (US) +1-214-272-0393



Leave a Reply